Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.59 |
| ▸ | CNR1 | P21554 | 3/20 | 0.58 |
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | MAPT | P10636 | 2/20 | 0.58 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | BLM | P54132 | 2/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.58 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.51 |
| ▸ | FAAH | O00519 | 1/20 | 0.51 |
| ▸ | KCNK3 | O14649 | 1/20 | 0.51 |
| ▸ | CNR2 | P34972 | 1/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3967869 | 1.00 | ALDH1A1 (0.59) | ALDH1A1CNR1HPGDMAPTTRPV1 | |
| SCHEMBL14972492 | 0.91 | ALDH1A1 (0.58) | ALDH1A1CNR1HPGDMAPTTRPV1 | |
| SCHEMBL5364934 | 0.90 | ALDH1A1 (0.66) | ALDH1A1CNR1HPGDMAPTTRPV1 | |
| SCHEMBL11327693 | 0.89 | ALDH1A1 (0.63) | ALDH1A1CNR1MAPTABCC4TSHR | |
| SCHEMBL5708430 | 0.89 | ALDH1A1 (0.63) | ALDH1A1CNR1MAPTABCC4TSHR | |
| SCHEMBL14125419 | 0.89 | ALDH1A1 (0.63) | ALDH1A1CNR1HPGDMAPTTRPV1 | |
| SCHEMBL5367095 | 0.89 | ALDH1A1 (0.63) | ALDH1A1CNR1HPGDMAPTTRPV1 | |
| SCHEMBL14972387 | 0.89 | ALDH1A1 (0.63) | ALDH1A1CNR1MAPTABCC4TSHR | |
| SCHEMBL13346193 | 0.86 | ALDH1A1 (0.66) | ALDH1A1CNR1HPGDMAPTTRPV1 | |
| SCHEMBL11343540 | 0.86 | ALDH1A1 (0.60) | ALDH1A1CNR1MAPTABCC4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10982174-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2021-04-20 | — | — | US | disclosed |
| US-20200040279-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2020-02-06 | — | — | US | disclosed |
| US-10322994-B2 | Fatty amides and derivatives from natural oil metathesis | STEPAN COMPANY (US) | 2019-06-18 | — | — | US | disclosed |
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-20170211016-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2017-07-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-9688944-B2 | Synergistic surfactant blends | STEPAN COMPANY (US) | 2017-06-27 | — | — | US | disclosed |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-06-08 | — | — | US | disclosed |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN CO (US) | 2017-06-08 | — | — | US | disclosed |
| US-9573884-B2 | Imidazoline amides and derivitives from natural oil metathesis | STEPAN COMPANY (US) | 2017-02-21 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN CO (US) | 2015-04-02 | — | — | US | disclosed |
| US-20130288946-A1 | LIGHT-DUTY LIQUID DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-10-31 | — | — | US | disclosed |
| US-20130288946-A1 | LIGHT-DUTY LIQUID DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-10-31 | — | — | US | disclosed |
| WO-2013162924-A1 | SYNERGISTIC SURFACTANT BLENDS | STEPAN COMPANY (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2013-08-29 | — | — | US | disclosed |
| WO-2012061110-A1 | LIGHT-DUTY LIQUID DETERGENTS BASED ON COMPOSITIONS DERIVED FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012061094-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | STEPAN COMPANY (US) | 2012-05-10 | — | — | WO | disclosed |
| WO-2012030524-A2 | FUNCTIONALIZED MALEATED FATTY ACIDS AS NON ACIDIC FLUID ADDITIVES | BAKER HUGHES INCORPORATED (US) | 2012-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130225470-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | SGMS1, DEGS1, DGAT2 | ALDH1A1 671/4885CNR1 802/4885HPGD 1902/4885 |
| US-20170158617-A1 | FATTY AMIDES AND DERIVATIVES FROM NATURAL OIL METATHESIS | DEGS1, SGMS1, DGAT2 | ALDH1A1 656/4885CNR1 830/4885HPGD 1901/4885 |
| US-10982174-B2 | Synergistic surfactant blends | HHAT, SQLE, SFN | ALDH1A1 2395/4885CNR1 2358/4885HPGD 4787/4885 |
| US-20150094383-A1 | SYNERGISTIC SURFACTANT BLENDS | HHAT, AADAT, SQLE | ALDH1A1 2198/4885CNR1 1379/4885HPGD 4608/4885 |
| US-20200040279-A1 | SYNERGISTIC SURFACTANT BLENDS | HHAT, SQLE, SFN | ALDH1A1 2395/4885CNR1 2358/4885HPGD 4787/4885 |
| US-10322994-B2 | Fatty amides and derivatives from natural oil metathesis | DEGS1, SGMS1, DGAT2 | ALDH1A1 656/4885CNR1 830/4885HPGD 1901/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.